MCA logo

PUBLIC PORTAL

Search Results for: lung cancer

small cell lung cancer roche

Roche reports positive five-year survival outcomes for extensive-stage small cell lung cancer

IMbrella A, an extension of the Phase III IMpower133 study, demonstrates the potential for a durable overall survival benefit with Tecentriq plus chemotherapy in extensive-stage small cell lung cancer (ES-SCLC)
IMbrella A data build on the previously reported IMpower133 trial, which was the first clinically meaningful advance in the treatment of ES-SCLC in more than twenty years

Log In or Register as a healthcare professional to read the full article.

Read More »
Roche’s Tecentriq® SC (atezolizumab) becomes the first subcutaneous anti-PD-(L)1 cancer immunotherapy available to patients in Singapore, reducing treatment time to a few minutes

Press Release – Roche’s Tecentriq® SC (atezolizumab) becomes the first subcutaneous anti-PD-(L)1 cancer immunotherapy available to patients in Singapore, reducing treatment time to a few minutes

Roche announced today that Tecentriq® SC (atezolizumab) has been approved by the Singapore Health Sciences Authority (HSA) for all indications in which the intravenous (IV) formulation of Tecentriq has been previously approved, including certain types of lung, breast and liver cancer.4 Tecentriq SC is Roche’s fourth subcutaneous cancer therapy,5-7 and the world’s first injectable anti-PD-(L)1 cancer immunotherapy.

Log In or Register as a healthcare professional to read the full article.

Read More »
Western Visayas Heart and Lung Center

Western Visayas Medical Center (WVMC) Heart and Lung Building: A Beacon of Excellence in Cardiovascular and Pulmonary Care

In a momentous occasion, the Western Visayas Medical Center (WVMC) unveiled its Heart and Lung building, marking a significant leap forward in the region’s healthcare landscape. Nestled in the heart of Western Visayas, this state-of-the-art facility stands as a beacon of excellence, offering comprehensive cardiovascular and pulmonary care services to patients across the region.

Read More »
Cancer luis campos CAF

Congress Allocates P1.25 Billion for Cancer Assistance Fund (CAF)

The eight priority cancer types identified by the DoH include the following. They are breast cancer, childhood cancers, gynecologic cancers, liver cancer (including colorectal and other digestive tract cancers), head and neck cancers (including thyroid), lung cancer, and prostate, renal, and urinary bladder cancer. The CAF aims to address the most pressing needs within cancer care and treatment by focusing on these priority areas.

Each cancer type presents unique challenges in prevention, early detection, and treatment. The allocation of funds for these specific areas reflects a strategic approach to resource allocation. This ensures that interventions are targeted and effective in addressing the burden of cancer across different population groups.

Read More »